SIGA Technologies (SIGA) Competitors $7.21 -0.01 (-0.14%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends SIGA vs. EBS, FLXN, NLTX, ORGO, GMTX, MIRM, HRMY, ARVN, RXRX, and CNTAShould you be buying SIGA Technologies stock or one of its competitors? The main competitors of SIGA Technologies include Emergent BioSolutions (EBS), Flexion Therapeutics (FLXN), Neoleukin Therapeutics (NLTX), Organogenesis (ORGO), Gemini Therapeutics (GMTX), Mirum Pharmaceuticals (MIRM), Harmony Biosciences (HRMY), Arvinas (ARVN), Recursion Pharmaceuticals (RXRX), and Centessa Pharmaceuticals (CNTA). These companies are all part of the "medical" sector. SIGA Technologies vs. Emergent BioSolutions Flexion Therapeutics Neoleukin Therapeutics Organogenesis Gemini Therapeutics Mirum Pharmaceuticals Harmony Biosciences Arvinas Recursion Pharmaceuticals Centessa Pharmaceuticals Emergent BioSolutions (NYSE:EBS) and SIGA Technologies (NASDAQ:SIGA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations, media sentiment and community ranking. Does the MarketBeat Community favor EBS or SIGA? Emergent BioSolutions received 413 more outperform votes than SIGA Technologies when rated by MarketBeat users. Likewise, 66.77% of users gave Emergent BioSolutions an outperform vote while only 23.81% of users gave SIGA Technologies an outperform vote. CompanyUnderperformOutperformEmergent BioSolutionsOutperform Votes41866.77% Underperform Votes20833.23% SIGA TechnologiesOutperform Votes523.81% Underperform Votes1676.19% Is EBS or SIGA more profitable? SIGA Technologies has a net margin of 48.55% compared to Emergent BioSolutions' net margin of -53.26%. SIGA Technologies' return on equity of 51.40% beat Emergent BioSolutions' return on equity.Company Net Margins Return on Equity Return on Assets Emergent BioSolutions-53.26% -34.38% -11.71% SIGA Technologies 48.55%51.40%39.58% Do analysts rate EBS or SIGA? Emergent BioSolutions presently has a consensus price target of $12.00, indicating a potential upside of 31.43%. Given Emergent BioSolutions' higher possible upside, research analysts plainly believe Emergent BioSolutions is more favorable than SIGA Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Emergent BioSolutions 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33SIGA Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the media favor EBS or SIGA? In the previous week, SIGA Technologies had 2 more articles in the media than Emergent BioSolutions. MarketBeat recorded 5 mentions for SIGA Technologies and 3 mentions for Emergent BioSolutions. Emergent BioSolutions' average media sentiment score of 0.51 beat SIGA Technologies' score of 0.39 indicating that Emergent BioSolutions is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Emergent BioSolutions 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SIGA Technologies 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders hold more shares of EBS or SIGA? 78.4% of Emergent BioSolutions shares are held by institutional investors. Comparatively, 55.4% of SIGA Technologies shares are held by institutional investors. 1.2% of Emergent BioSolutions shares are held by company insiders. Comparatively, 1.5% of SIGA Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, EBS or SIGA? Emergent BioSolutions has a beta of 1.59, suggesting that its share price is 59% more volatile than the S&P 500. Comparatively, SIGA Technologies has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500. Which has better valuation and earnings, EBS or SIGA? SIGA Technologies has lower revenue, but higher earnings than Emergent BioSolutions. Emergent BioSolutions is trading at a lower price-to-earnings ratio than SIGA Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEmergent BioSolutions$1.05B0.46-$760.50M-$11.24-0.81SIGA Technologies$139.92M3.68$68.07M$1.176.16 SummarySIGA Technologies beats Emergent BioSolutions on 9 of the 17 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get SIGA Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIGA vs. The Competition Export to ExcelMetricSIGA TechnologiesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$514.58M$7.03B$5.40B$8.53BDividend YieldN/A7.96%5.13%4.14%P/E Ratio6.169.93115.5615.18Price / Sales3.68381.421,484.3492.77Price / Cash7.4847.3439.6634.07Price / Book2.605.324.665.02Net Income$68.07M$153.56M$119.06M$225.46M7 Day Performance6.50%0.11%0.80%0.37%1 Month Performance4.19%15.22%5.65%3.57%1 Year Performance47.44%41.14%36.76%29.44% SIGA Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIGASIGA Technologies2.7842 of 5 stars$7.21-0.1%N/A+42.5%$514.58M$139.92M6.1640Upcoming EarningsOptions VolumeEBSEmergent BioSolutions4.3493 of 5 stars$9.12+0.7%$12.00+31.6%+365.8%$482.54M$1.05B-0.811,600Upcoming EarningsShort Interest ↓FLXNFlexion TherapeuticsN/A$9.12flatN/AN/A$458.93M$85.55M-4.54257Analyst ForecastNLTXNeoleukin TherapeuticsN/A$46.07+4.7%N/A+240.8%$432.97MN/A-14.8190ORGOOrganogenesis4.1493 of 5 stars$2.78+0.4%$4.88+75.4%+21.4%$368.56M$448.39M-21.38950News CoverageGMTXGemini TherapeuticsN/A$47.13+5.2%N/A+2.9%$2.04BN/A-47.1330MIRMMirum Pharmaceuticals4.5647 of 5 stars$40.40+5.0%$56.82+40.6%+42.2%$1.93B$186.37M-17.64140Upcoming EarningsNews CoverageHRMYHarmony Biosciences4.9032 of 5 stars$33.08+3.0%$47.00+42.1%+34.9%$1.89B$582.02M15.68200Earnings ReportAnalyst ForecastInsider SellingShort Interest ↓Analyst RevisionNews CoverageHigh Trading VolumeARVNArvinas2.1178 of 5 stars$26.90+1.8%$56.92+111.6%+68.3%$1.85B$161.10M-5.76445Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews CoverageRXRXRecursion Pharmaceuticals2.9187 of 5 stars$6.40+1.3%$9.40+46.9%+25.7%$1.80B$44.58M-3.95400Upcoming EarningsCNTACentessa Pharmaceuticals3.456 of 5 stars$15.67+4.2%$25.17+60.6%+128.8%$1.78B$6.85M-10.0472 Related Companies and Tools Related Companies Emergent BioSolutions Alternatives Flexion Therapeutics Alternatives Neoleukin Therapeutics Alternatives Organogenesis Alternatives Gemini Therapeutics Alternatives Mirum Pharmaceuticals Alternatives Harmony Biosciences Alternatives Arvinas Alternatives Recursion Pharmaceuticals Alternatives Centessa Pharmaceuticals Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SIGA) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SIGA Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SIGA Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
